Short answer
Phathom Pharmaceuticals, Inc. (PHAT) filed an 8-K current report with the SEC on May 21, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders reelected Steven Basta, Theodore R. Schroeder, and Mark Stenhouse as Class I directors through the 2029 annual meeting.
Phathom Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders reelected Steven Basta, Theodore R. Schroeder, and Mark Stenhouse as Class I directors through the 2029 annual meeting
- Director support remained strong, with 41,249,990–42,656,800 votes for each nominee
- Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 64,482,757 votes for
- Advisory say-on-pay proposal approved with 44,449,761 votes for and 2,532,145 against
- Results support board continuity, auditor retention, and shareholder approval of executive compensation practices
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Phathom Pharmaceuticals, Inc. 8-K filings
Get the next PHAT 8-K as it lands
Follow PHAT for push alerts, or ask the research agent what this filing means.